Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|August 10, 2019
Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>Krishna B Singh, Eun-Ryeong Hahm, Subrata K Pore, et al.
American Journal of Physiology. Renal Physiology|November 3, 2017
BDNF overexpression in the bladder induces neuronal changes to mediate bladder overactivityMahendra P Kashyap, Subrata K Pore, William C de Groat, et al.
Carcinogenesis|October 18, 2017
Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanateSubrata K Pore, Eun-Ryeong Hahm, Joseph D Latoche, et al.
Journal of Cellular Biochemistry|August 14, 2019
N-end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and RAD21 protein expressionSubrata K Pore, Anirban Ganguly, Samaresh Sau, et al.
Seminars in Cancer Biology|November 22, 2016
Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plantsAnuradha Sehrawat, Ruchi Roy, Subrata K Pore, et al.
Journal of the National Cancer Institute|January 2, 2017
Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin ASuman K Samanta, Anuradha Sehrawat, Su-Hyeong Kim, et al.
Molecular Cancer Therapeutics|December 1, 2019
A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer-Induced Osteolytic Bone ResorptionSubrata K Pore, Eun-Ryeong Hahm, Su-Hyeong Kim, et al.
Pageof 1